One of the criteria of the selection of potential biomarkers was the differential expression not only between cancer and normal BEAS-2B cell lines, but also between A549 and HCC827 LC cells different in mutation status of the EGFR gene, one of the major pathological parameters in LC. Here, EGFR is linked to laryngotracheoesophageal cleft.